Citation: | Shuhua LI, Tingting CHEN, Yukun LIU, Hao LI, Yiying CHENG, Yajie ZHANG. Construct ion of recombinant adenovirus vector pDC316-hIL-24 and the detection of viral titer[J]. Journal of Molecular Imaging, 2014, 37(3): 135-139. doi: 10.3969/j.issn.1674-4500.2014.03.01 |
[1] |
Jiang H, Lin JJ, Su ZZ, et al. subtraction hybrid ization identifies a novel melanoma differentiation associated gene, MDA-7, modulated during human m elanom a differentiation, growth and progression[J]. Oncogene, 1995, 11(12): 2477-86.
|
[2] |
Yacoub A, Mitchell C, Lebedeva IV, et al. mda-7(IL-24) inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling[J]. Cancer Biol Ther, 2003, 2(4): 347-53. doi: 10.4161/cbt.2.4.422
|
[3] |
Nishikawa T, Ramesh R, Munshi A, et al. Adenovirus-mediated mda-7(IL-24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation, Mol[J]. 2003: 9.
|
[4] |
Dumoutier L, Leemans C, Lejeune D, et al. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types[J]. Journal of Immunology, 2001, 167(7): 3545-9. doi: 10.4049/jimmunol.167.7.3545
|
[5] |
Madireddi MT, Su ZZ, Young CS, et al. Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy[J]. Adv Exp Med Biol, 2000, 465: 239-61.
|
[6] |
Lebedeva IV, Sauane M, Gopalkrishnan RV, et al. mda-7/IL-24: exploiting cancer's Achilles' heel[J]. Mol Ther, 2005, 11(1): 4-18. doi: 10.1016/j.ymthe.2004.08.012
|
[7] |
Fisher PB. Is mda-7/IL-24 a"magic"bullet, for cancer[J]? Cancer Res, 2005, 65(22): 25. https://www.ncbi.nlm.nih.gov/pubmed/16287994
|
[8] |
Gupta P, Su ZZ, Lebedeva IV, et al. Mda-7/IL-24:multifunetional cancer-specific apoptosis-inducing eytokine[J]. 2006. http://www.google.it/patents/CA2368927A1?cl=en
|
[9] |
Romano G, Pacilio C, Giordano A. Gene transfer technology in therapy: current applications and future goals[J]. Stem Cells, 1999, 17(4): 191-202. doi: 10.1002/stem.v17:4
|
[10] |
Nielsen LL, Gurnani M, Syed J, et al. Recombinant E1-deleted adenovims-mediated gene therapy for cancer:efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models[J]. Hum Gene Ther, 1998, 9(5): 681-94. doi: 10.1089/hum.1998.9.5-681
|
[11] |
Douglas. Adenoviral vectors for gene therapy[J]. Mol Biotechnol, 2007, 36(1): 71-80. doi: 10.1007/s12033-007-0021-5
|